These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38046278)

  • 1. Spleen-Derived CCL9 Recruits MDSC to Facilitate Tumor Growth in Orthotopic Hepatoma Mice.
    Li B; Li W; Liang Y; Zhang C; Kong G; Li Z
    Glob Med Genet; 2023 Dec; 10(4):348-356. PubMed ID: 38046278
    [No Abstract]   [Full Text] [Related]  

  • 2. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
    Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
    Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spleen contributes to the increase in PMN-MDSCs in orthotopic H22 hepatoma mice.
    Li BH; Jiang W; Zhang S; Huang N; Sun J; Yang J; Li ZF
    Mol Immunol; 2020 Sep; 125():95-103. PubMed ID: 32659598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and significance of myeloid-derived suppressor cells-associated chemokine MIP-1γ and its receptor CCR1 in the spleen of hepatoma H22-bearing mice].
    Li B; Chen H; Shi M; Huang N; Kong G; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Sep; 36(9):802-808. PubMed ID: 32967764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of the spleen and its significance in a murine H22 orthotopic hepatoma model.
    Li B; Zhang S; Huang N; Chen H; Wang P; Li J; Pu Y; Yang J; Li Z
    Exp Biol Med (Maywood); 2016 Apr; 241(8):863-72. PubMed ID: 26989085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo.
    Long X; Wang J; Zhao JP; Liang HF; Zhu P; Cheng Q; Chen Q; Wu YH; Zhang ZG; Zhang BX; Chen XP
    J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):667-676. PubMed ID: 27752888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spleen contributes to restraint stress induced hepatocellular carcinoma progression.
    Jiang W; Li Y; Wei W; Li JW; Li L; Zhang C; Zhang SQ; Kong GY; Li ZF
    Int Immunopharmacol; 2020 Jun; 83():106420. PubMed ID: 32203905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-Interacting Protein Kinase 3 Deficiency Recruits Myeloid-Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C-X-C Motif) Ligand 1-Chemokine (C-X-C Motif) Receptor 2 Axis.
    Li YM; Liu ZY; Wang JC; Yu JM; Li ZC; Yang HJ; Tang J; Chen ZN
    Hepatology; 2019 Nov; 70(5):1564-1581. PubMed ID: 31021443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
    Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
    J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variation of subsets of myeloid derived suppressor cells and their ratio in septic mice].
    Wang H; Zhao Q; Huang Z; Zhao M; Xu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):147-52. PubMed ID: 26911947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.
    Yan HH; Jiang J; Pang Y; Achyut BR; Lizardo M; Liang X; Hunter K; Khanna C; Hollander C; Yang L
    Cancer Res; 2015 Dec; 75(24):5283-98. PubMed ID: 26483204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between cellular immune response and spleen weight in mice with hepatocellular carcinoma.
    Jiang W; Li Y; Zhang S; Kong G; Li Z
    Oncol Lett; 2021 Aug; 22(2):625. PubMed ID: 34267817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
    Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
    Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
    Hu CE; Gan J; Zhang RD; Cheng YR; Huang GJ
    Scand J Gastroenterol; 2011 Feb; 46(2):156-64. PubMed ID: 20822377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-derived suppressor cell accumulation in renal cell carcinoma is correlated with CCL2, IL-17 and IL-18 expression in blood and tumors.
    Guan X; Liu Z; Zhang J; Jin X
    Adv Clin Exp Med; 2018 Jul; 27(7):947-953. PubMed ID: 29905412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.
    Pilon-Thomas S; Nelson N; Vohra N; Jerald M; Pendleton L; Szekeres K; Ghansah T
    PLoS One; 2011; 6(11):e27729. PubMed ID: 22132131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking the A
    Yu Z; Ling Y; Xu Q; Cao Y; Tang S; Fu C
    Ann Med; 2022 Dec; 54(1):1616-1626. PubMed ID: 35675334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.
    Li H; Han Y; Guo Q; Zhang M; Cao X
    J Immunol; 2009 Jan; 182(1):240-9. PubMed ID: 19109155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine CCL9 Is Upregulated Early in Chronic Kidney Disease and Counteracts Kidney Inflammation and Fibrosis.
    Hemmers C; Schulte C; Wollenhaupt J; Wong DWL; Harlacher E; Orth-Alampour S; Klinkhammer BM; Schirmer SH; Böhm M; Marx N; Speer T; Boor P; Jankowski J; Noels H
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.